Vit b12 cyanocobalamin
Pro Research Analysisby 
Searched over 200M research papers
Cyanocobalamin (Vitamin B12): Applications and Efficacy
Cyanocobalamin in Seasonal Affective Disorder (SAD) Treatment
Cyanocobalamin, a form of vitamin B12, has been investigated for its potential to treat winter seasonal affective disorder (SAD). A controlled trial involving 27 patients with SAD compared the effects of cyanocobalamin (1.5 mg, three times daily) to a placebo over a two-week period. The study found no significant differences in antidepressant efficacy between the two groups, suggesting that cyanocobalamin is not an effective short-term treatment for depression in SAD patients.
Electrocatalytic Properties of Cyanocobalamin
Cyanocobalamin also exhibits unique properties beyond its nutritional value. It acts as a robust electrocatalyst for water oxidation under neutral conditions, achieving a faradaic efficiency of 97.50% at an overpotential of approximately 0.58 V. This stability and efficiency make it a promising candidate for applications in sustainable energy solutions.
Pharmacokinetics and Bioavailability of Oral Cyanocobalamin
The bioavailability of oral cyanocobalamin can be significantly enhanced using absorption enhancers. A study comparing a standard cyanocobalamin tablet to one formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC) found that the SNAC formulation had greater mean absolute bioavailability (5.09% vs. 2.16%) and a reduced time to maximum concentration (T_max) (0.5 hours vs. 6.83 hours). This suggests that SNAC can improve the uptake of cyanocobalamin, making oral supplementation more effective.
Transport Across the Blood-Retinal Barrier
Research into the transport mechanisms of cyanocobalamin across the blood-retinal barrier (BRB) has shown that it involves receptor-mediated endocytosis. Fluorescence-labeled cyanocobalamin studies demonstrated its distribution in various retinal layers and its uptake by BRB cells, facilitated by the transcobalamin II receptor. This indicates a specific and efficient transport mechanism for vitamin B12 to the retina.
Cytotoxicity and Protective Effects in Cell Culture
Cyanocobalamin derivatives, such as cyanocobalamin [c-lactam], can antagonize vitamin B12 and cause cytotoxicity in cell cultures. In HL60 cells, this derivative caused cell death, which was reversible with additional vitamin B12. Methionine supplementation completely protected the cells, highlighting the importance of methionine in counteracting the cytotoxic effects of cyanocobalamin [c-lactam].
Vitamin B12 for Pain Management
Vitamin B12, including cyanocobalamin, has been explored as a treatment for pain. Animal studies suggest that vitamin B12 can aid in nerve regeneration and inhibit pain-signaling pathways. Clinical trials have shown some effectiveness in treating low back pain and neuralgia, although more research is needed to establish optimal dosing and efficacy.
Enhanced Solubility and Stability of Cyanocobalamin Conjugates
Conjugation of cyanocobalamin with various compounds can significantly enhance its solubility and stability. For instance, conjugates with glycolates can increase solubility up to 19-fold. These findings are crucial for developing more effective vitamin B12 supplements and drug delivery systems.
Microencapsulation for Improved Stability
Microencapsulation using the spray chilling technique has been shown to improve the stability of cyanocobalamin. Solid lipid microparticles (SLM) loaded with vitamin B12 demonstrated high encapsulation efficiency and better protection against degradation compared to free vitamin B12. This method offers a promising approach to enhance the shelf life and efficacy of vitamin B12 supplements.
Effects on Growth and Hematological Indicators in Ducks
A study on male Pekin ducks from hatch to 21 days of age found that supplemental cyanocobalamin did not significantly affect growth performance but improved hematological parameters. The optimal dietary requirement was determined to be 0.02 mg/kg of feed, which enhanced white and red blood cell counts and platelet counts.
Inhibition of Glutamate Release in Nerve Terminals
Cyanocobalamin has been found to inhibit glutamate release in rat cerebrocortical nerve terminals by reducing voltage-dependent calcium influx. This inhibition is mediated through a decrease in protein kinase C activation, which subsequently reduces calcium entry through N- and P/Q-type calcium channels. This mechanism highlights a potential neuroprotective role of cyanocobalamin.
Conclusion
Cyanocobalamin (vitamin B12) exhibits a wide range of applications, from nutritional supplementation to potential therapeutic uses in pain management and neuroprotection. While it shows promise in various fields, further research is needed to fully understand its mechanisms and optimize its efficacy in clinical settings.
Sources and full results
Most relevant research papers on this topic